Literature DB >> 21525022

Influence of multidrug efflux systems on methylene blue-mediated photodynamic inactivation of Candida albicans.

Renato A Prates1, Ilka T Kato, Martha S Ribeiro, George P Tegos, Michael R Hamblin.   

Abstract

OBJECTIVES: To investigate whether the major fungal multidrug efflux systems (MESs) affect the efficiency of methylene blue (MB)-mediated antimicrobial photodynamic inactivation (APDI) in pathogenic fungi and test specific inhibitors of these efflux systems to potentiate APDI.
METHODS: Candida albicans wild-type and mutants that overexpressed two classes of MESs [ATP-binding cassette (ABC) and major facilitator superfamily (MFS)] were tested for APDI using MB as the photosensitizer with and without addition of MES inhibitors. The uptake and cytoplasm localization of photosensitizer were achieved using laser confocal microscopy.
RESULTS: ABC MES overexpression reduced MB accumulation and APDI killing more than MFS MES overexpression. Furthermore, by combining MB APDI with the ABC inhibitor verapamil, fungal killing and MB uptake were potentiated, while by combining MB APDI with the MFS inhibitor INF(271), fungal killing and MB uptake were inhibited. This latter surprising finding may be explained by the hypothesis that the MFS channel can also serve as an uptake mechanism for MB.
CONCLUSIONS: The ABC pumps are directly implicated in MB efflux from the cell cytoplasm. Both the influx and efflux of MB may be regulated by MFS systems, and blocking this gate before incubation with MB can decrease the uptake and APDI effects. An ABC inhibitor could be usefully combined with MB APDI for treating C. albicans infections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21525022      PMCID: PMC3112030          DOI: 10.1093/jac/dkr160

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  52 in total

1.  Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials.

Authors:  George Tegos; Frank R Stermitz; Olga Lomovskaya; Kim Lewis
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

Review 2.  Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005-2009).

Authors:  Ana Espinel-Ingroff
Journal:  Rev Iberoam Micol       Date:  2009-05-07       Impact factor: 1.044

3.  The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.

Authors:  D Sanglard; F Ischer; D Calabrese; P A Majcherczyk; J Bille
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

4.  The phototoxicity of phenothiazinium derivatives against Escherichia coli and Staphylococcus aureus.

Authors:  D A Phoenix; Z Sayed; S Hussain; F Harris; M Wainwright
Journal:  FEMS Immunol Med Microbiol       Date:  2003-10-24

Review 5.  Evolution of drug resistance in Candida albicans.

Authors:  Leah E Cowen; James B Anderson; Linda M Kohn
Journal:  Annu Rev Microbiol       Date:  2002-01-30       Impact factor: 15.500

Review 6.  Photodynamic therapy for cancer.

Authors:  Dennis E J G J Dolmans; Dai Fukumura; Rakesh K Jain
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

7.  Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast.

Authors:  Manuela Schuetzer-Muehlbauer; Birgit Willinger; Ralf Egner; Gerhard Ecker; Karl Kuchler
Journal:  Int J Antimicrob Agents       Date:  2003-09       Impact factor: 5.283

8.  Assessment of photodynamic destruction of Escherichia coli O157:H7 and Listeria monocytogenes by using ATP bioluminescence.

Authors:  N A Romanova; L Y Brovko; L Moore; E Pometun; A P Savitsky; N N Ugarova; M W Griffiths
Journal:  Appl Environ Microbiol       Date:  2003-11       Impact factor: 4.792

9.  Detection of human P-glycoprotein-like molecule in azole-resistant Candida albicans from HIV+ patients.

Authors:  Annarita Stringaro; Agnese Molinari; Annarica Calcabrini; Giuseppe Arancia; Pier Giuseppe Ceddia; Maurizio Cianfriglia; Francesca Poloni; Francesca Mondello; Letizia Angiolella; Flavia De Bernardis; Antonio Cassone
Journal:  Microb Drug Resist       Date:  2002       Impact factor: 3.431

10.  Oral bacteria in multi-species biofilms can be killed by red light in the presence of toluidine blue.

Authors:  John F O'Neill; Christopher K Hope; Michael Wilson
Journal:  Lasers Surg Med       Date:  2002       Impact factor: 4.025

View more
  30 in total

1.  Blue dye and red light, a dynamic combination for prophylaxis and treatment of cutaneous Candida albicans infections in mice.

Authors:  Tianhong Dai; Vida J Bil de Arce; George P Tegos; Michael R Hamblin
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Miconazole induces fungistasis and increases killing of Candida albicans subjected to photodynamic therapy.

Authors:  Sara B Snell; Thomas H Foster; Constantine G Haidaris
Journal:  Photochem Photobiol       Date:  2011-12-20       Impact factor: 3.421

3.  Photodynamic antimicrobial chemotherapy (PACT) inhibits biofilm formation by Candida albicans, increasing both ROS production and membrane permeability.

Authors:  Isabela Bueno Rosseti; Luciene Reginato Chagas; Maricilia Silva Costa
Journal:  Lasers Med Sci       Date:  2013-11-01       Impact factor: 3.161

4.  Photodynamic inactivation of Paracoccidioides brasiliensis helps the outcome of oral paracoccidiodomycosis.

Authors:  Letícia F M Dos Santos; Nathália B Melo; Marina L de Carli; Ana Carolina S C Mendes; Giulia Maria A C Bani; Liana M Verinaud; Eva Burger; Gabriel de Oliveira I Moraes; Alessandro A C Pereira; Maísa R L Brigagão; João Adolfo C Hanemann; Felipe F Sperandio
Journal:  Lasers Med Sci       Date:  2017-03-27       Impact factor: 3.161

5.  Photodynamic therapy as an antifungal treatment.

Authors:  Y I Liang; Li-Ming Lu; Yong Chen; You-Kun Lin
Journal:  Exp Ther Med       Date:  2016-05-11       Impact factor: 2.447

Review 6.  Strategies to potentiate antimicrobial photoinactivation by overcoming resistant phenotypes.

Authors:  Domingo Mariano Adolfo Vera; Mark H Haynes; Anthony R Ball; Tianhong Dai; Christos Astrakas; Michael J Kelso; Michael R Hamblin; George P Tegos
Journal:  Photochem Photobiol       Date:  2012-02-13       Impact factor: 3.421

7.  Advances in antimicrobial photodynamic inactivation at the nanoscale.

Authors:  Nasim Kashef; Ying-Ying Huang; Michael R Hamblin
Journal:  Nanophotonics       Date:  2017-08-01       Impact factor: 8.449

Review 8.  All you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease.

Authors:  Tyler G St Denis; Tianhong Dai; Leonid Izikson; Christos Astrakas; Richard Rox Anderson; Michael R Hamblin; George P Tegos
Journal:  Virulence       Date:  2011-11-01       Impact factor: 5.882

9.  Antimicrobial photodynamic inactivation inhibits Candida albicans virulence factors and reduces in vivo pathogenicity.

Authors:  Ilka Tiemy Kato; Renato Araujo Prates; Caetano Padial Sabino; Beth Burgwyn Fuchs; George P Tegos; Eleftherios Mylonakis; Michael R Hamblin; Martha Simões Ribeiro
Journal:  Antimicrob Agents Chemother       Date:  2012-11-05       Impact factor: 5.191

10.  Photodynamic antimicrobial chemotherapy (PACT) using toluidine blue inhibits both growth and biofilm formation by Candida krusei.

Authors:  Bruna Graziele Marques da Silva; Moisés Lopes Carvalho; Isabela Bueno Rosseti; Stella Zamuner; Maricilia Silva Costa
Journal:  Lasers Med Sci       Date:  2018-01-13       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.